Chief Business Officer
Padma Sundar has close to 15 years of experience in the genomics and molecular diagnostics industry with leadership roles in strategy, marketing, sales, and reimbursement at Oncocyte, Roche Sequencing, Guardant Health and Affymetrix. She is experienced in securing high value reimbursement values and launching multiple ground-breaking technologies in the oncology field. Padma began her career as a consultant with McKinsey and company. She has a bachelor’s in chemistry and an MBA and Masters in Public Health from UC Berkeley.